These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9713262)

  • 1. Chemotherapy is antihormonal therapy--how much proof do oncologists need?
    Jordan VC
    Eur J Cancer; 1998 Apr; 34(5):606-8. PubMed ID: 9713262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].
    Bershteĭn LM; Semiglazov VF
    Vopr Onkol; 2011; 57(5):559-66. PubMed ID: 22238924
    [No Abstract]   [Full Text] [Related]  

  • 3. Special issue on steroids and cancer. Preface.
    Geisler J; Sasano H
    J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):67. PubMed ID: 22732368
    [No Abstract]   [Full Text] [Related]  

  • 4. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current issues in adjuvant hormone therapy of breast cancer].
    Semiglazov VF; Semiglazov VV
    Vopr Onkol; 2003; 49(6):771-5. PubMed ID: 14976929
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen in early breast cancer.
    Arriagada R
    Lancet; 1998 Aug; 352(9125):403-4. PubMed ID: 9717953
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone Therapy in Breast Cancer.
    Drăgănescu M; Carmocan C
    Chirurgia (Bucur); 2017; 112(4):413-417. PubMed ID: 28862117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current topics and perspectives in the treatment of endocrine-related cancers.
    Iwase H
    Int J Clin Oncol; 2008 Oct; 13(5):377-9. PubMed ID: 18946746
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
    Atkins CD
    J Natl Cancer Inst; 1998 Mar; 90(6):468-9. PubMed ID: 9521174
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer].
    Semiglazov VF; Kanaev SV; Bugrova IL; Chagunava OL
    Vopr Onkol; 1998; 44(4):408-13. PubMed ID: 9807203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian suppression for breast cancer: an effective treatment in search of a home.
    Krop IE; Winer EP
    J Clin Oncol; 2005 Sep; 23(25):5869-72. PubMed ID: 16087947
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant hormonal therapy for premenopausal breast cancer: incorporating clinical experience.
    Nasim S; Pritchard KI
    Oncology (Williston Park); 2010 Apr; 24(4):332, 337, 340. PubMed ID: 20464844
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.
    Briest S; Wolff AC
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1243-53. PubMed ID: 17892424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK; Kamby C; Nielsen DL
    Ugeskr Laeger; 2007 Sep; 169(37):3077-81. PubMed ID: 17877952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
    Cianfrocca M; Wolff AC
    Oncology (Williston Park); 2007 Jan; 21(1):63-9; discussion 69, 72, 75 passim. PubMed ID: 17313157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ; Davidson NE
    Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issues.
    Goldhirsch A; Price KN
    Oncology (Williston Park); 2010 Apr; 24(4):331-2. PubMed ID: 20464843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer.
    Altundag K; Altundag O; Gunduz M
    Breast Cancer Res Treat; 2005 Jan; 89(2):213. PubMed ID: 15692765
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do.
    Higgins MJ; Wolf AC
    Oncology (Williston Park); 2009 Jan; 23(1):40, 42, 44. PubMed ID: 19283920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.